Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors

• Kevin Conlon,
• Douglas G McNeel,
• John A Thompson,
• Sema Kurtulus,
• Rom Leidner,
• Thomas A Waldmann,
• Andrea Wang-Gillam,
• William D Figg,
• Sumati Gupta,
• Cristina Bergamaschi,
• George N Pavlakis,
• Antonio Valentin,
• Barbara K Felber,
• Mario Roederer,
• Dionysios C Watson,
• Cody J Peer,
• E Lake Potter,
• Nehal S Parikh,
• Debby Long,
• Lang Ho Lee,
• Niladri Roy Chowdhury,
• Florent Bender

Affiliations

Kevin Conlon

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA

Douglas G McNeel

Carbone Cancer Center, University of Wisconsin Madison, Madison, Wisconsin, USA

John A Thompson

Seattle Cancer Care Alliance, Seattle, Washington, USA

Sema Kurtulus

Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA

Rom Leidner

Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA

Thomas A Waldmann

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA

Andrea Wang-Gillam

Division of Oncology, Department of Medicine, Washington University in Saint Louis, St Louis, Missouri, USA

William D Figg

Clinical Pharmacology Program, Center for Cancer Research, NCI, Bethesda, Maryland, USA

Sumati Gupta

Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA

Cristina Bergamaschi

Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA

George N Pavlakis

Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA

Antonio Valentin

Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA

Barbara K Felber

Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA

Mario Roederer

Vaccine Research Center, NIAID, Bethesda, Maryland, USA

Dionysios C Watson

Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, USA

Cody J Peer

Clinical Pharmacology Program, Center for Cancer Research, NCI, Bethesda, Maryland, USA

E Lake Potter

Vaccine Research Center, NIAID, Bethesda, Maryland, USA

Nehal S Parikh

Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA

Debby Long

Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA

Lang Ho Lee

Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA

Niladri Roy Chowdhury

Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA

Florent Bender

Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA